164 related articles for article (PubMed ID: 7653889)
21. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.
Horii Y; Ikenaga M; Shimoda M; Kokue E
J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102
[TBL] [Abstract][Full Text] [Related]
22. Flunixin inhibits prostaglandin E2 production in equine inflammation.
Lees P; Higgins AJ
Res Vet Sci; 1984 Nov; 37(3):347-9. PubMed ID: 6596664
[TBL] [Abstract][Full Text] [Related]
23. The impact of pain on the pharmacokinetics of transdermal flunixin meglumine administered at the time of cautery dehorning in Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; Kleinhenz KE; Kukanich B; Rajewski SM; Walsh P; Coetzee JF
Vet Anaesth Analg; 2018 Nov; 45(6):849-857. PubMed ID: 30122634
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interactions between flunixin and sulphadimidine in horses.
el-Banna HA
Dtsch Tierarztl Wochenschr; 1999 Sep; 106(9):400-3. PubMed ID: 10547934
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Cheng Z; McKeller Q; Nolan A
J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
Arifah AK; Lees P
J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
Coakley M; Peck KE; Taylor TS; Matthews NS; Mealey KL
Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
[TBL] [Abstract][Full Text] [Related]
28. Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys.
Cheng Z; McKellar Q; Nolan A; Lees P
Vet Res Commun; 1996; 20(5):469-72. PubMed ID: 8908727
[No Abstract] [Full Text] [Related]
29. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin.
Jackman BR; Moore JN; Barton MH; Morris DD
Can J Vet Res; 1994 Apr; 58(2):138-43. PubMed ID: 8004539
[TBL] [Abstract][Full Text] [Related]
30. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
Pellegrini-Masini A; Poppenga RH; Sweeney RW
J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of intravenous and transdermal flunixin meglumine in meat goats.
Reppert EJ; Kleinhenz MD; Montgomery SR; Bornheim HN; Magnin G; Sidhu PK; Zhang Y; Joo H; Coetzee JF
J Vet Pharmacol Ther; 2019 May; 42(3):309-317. PubMed ID: 30802981
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and tissue elimination of flunixin in veal calves.
Kissell LW; Brinson PD; Gehring R; Tell LA; Wetzlich SE; Baynes RE; Riviere JE; Smith GW
Am J Vet Res; 2016 Jun; 77(6):634-40. PubMed ID: 27227502
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics and pharmacokinetics of flunixin in the cat.
Lees P; Taylor PM
Br Vet J; 1991; 147(4):298-305. PubMed ID: 1913126
[TBL] [Abstract][Full Text] [Related]
34. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of flunixin meglumine in swine after intravenous dosing.
Buur JL; Baynes RE; Smith G; Riviere JE
J Vet Pharmacol Ther; 2006 Oct; 29(5):437-40. PubMed ID: 16958790
[No Abstract] [Full Text] [Related]
36. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of flunixin meglumine in dogs.
Hardie EM; Hardee GE; Rawlings CA
Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
[TBL] [Abstract][Full Text] [Related]
38. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus).
Leavens TL; Tell LA; Kissell LW; Smith GW; Smith DJ; Wagner SA; Shelver WL; Wu H; Baynes RE; Riviere JE
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(9):1506-21. PubMed ID: 25082521
[TBL] [Abstract][Full Text] [Related]
39. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
Kopcha M; Ahl AS
J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats.
Königsson K; Törneke K; Engeland IV; Odensvik K; Kindahl H
Acta Vet Scand; 2003; 44(3-4):153-9. PubMed ID: 15074628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
